Street Calls of the Week
Alison Moore, Chief Technical Officer of Codexis, Inc. (NASDAQ:CDXS), a $246 million market cap biotechnology company, sold 6,239 shares of common stock on October 13, 2025, according to a Form 4 filing with the Securities and Exchange Commission. The shares were sold at a price of $2.5051, for a total transaction value of $15,629. The stock, currently trading at $2.74, has shown significant volatility this year, according to InvestingPro data.
The sale was executed to cover tax obligations related to the vesting of restricted stock units. Following the transaction, Moore directly owns 169,332 shares of Codexis , Inc., including 33,333 restricted stock units. With the company’s next earnings report due on October 30, InvestingPro subscribers can access detailed financial analysis and 7 additional key insights about CDXS’s performance and outlook.
The sale was signed off by Georgia Erbez, as Attorney-in-Fact for Alison Moore. The transaction comes as Codexis trades between its 52-week range of $1.90 to $6.08, with comprehensive analysis available in the Pro Research Report on InvestingPro.
In other recent news, Codexis, Inc. reported its second-quarter 2025 financial results, showing a significant revenue increase to $15.3 million from $8.0 million in the same period last year. The company also posted a reduced net loss of $13.3 million or ($0.16) per share, which exceeded analyst expectations of -$0.19 per share. Stifel reiterated its Buy rating on Codexis, highlighting the company’s revenue beat and positive updates on its Pharma Biocatalysis business and ECO Synthesis Platform. Meanwhile, Cantor Fitzgerald maintained its Overweight rating with an $11 price target, noting the strengthening of Codexis’s balance sheet, which provides funding for development costs. Benchmark, however, reiterated a Hold rating on the stock after the earnings release. Codexis’s financial reinforcement and operational developments appear to align with the positive outlook from analysts. These recent developments provide a snapshot of the company’s current financial and operational status.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.